China Approves First Coronavirus Drugs, Rushes Two Vaccine Trials
Can China Ace The Race?
Executive Summary
A coronavirus vaccine race is on in China with three domestic developers leading the charge, while traditional medicines are pioneering the drug race after the first official approvals of treatments for COVID-19.
You may also be interested in...
As China Promotes TCMs, Ban Against Criticizing The Remedies Proposed In Beijing Province
In a key step to prop up traditional Chinese medicines, Beijing has proposed a law that could potentially punish any vocal doubters. The move signals a familiar pattern as China resorts to using old approaches when facing a flurry of new challenges.
As China Glorifies Traditional Medicines, Doubters See A Haunted Past
In a key step to prop up traditional Chinese medicines, Beijing has proposed a law that could potentially punish any vocal doubters. The move signals a familiar pattern as China resorts to using old approaches when facing a flurry of new challenges.
China, US Carve Own Paths But Physicians Urge Collaboration With Vaccines Years Away
Despite different approaches, top virologists and renowned front-line physicians from China and the US see the need to share clinical experiences and for global cooperation on treatments and vaccines as economies start re-opening amid fear of a second wave.